Cancers (ISSN: 2072-6694) is an open access journal, allowing you to have free and unlimited access to all full-text articles. We welcome you to read the following feature papers published in the second half of 2024 in the “Cancer Biomarkers” Section:

1. “Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo and Deniz Can Guven
Cancers 2024, 16(21), 3689; https://doi.org/10.3390/cancers16213689
Available online: https://www.mdpi.com/2072-6694/16/21/3689

2. “Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review”
by Juan Carlos Restrepo, Darly Martínez Guevara, Andrés Pareja López, John Fernando Montenegro Palacios and Yamil Liscano
Cancers 2024, 16(13), 2338; https://doi.org/10.3390/cancers16132338
Available online: https://www.mdpi.com/2072-6694/16/13/2338

3. “Advances in Personalized Oncology”
by Hiba Mechahougui, James Gutmans, Gina Colarusso, Roumaïssa Gouasmi and Alex Friedlaender
Cancers 2024, 16(16), 2862; https://doi.org/10.3390/cancers16162862
Available online: https://www.mdpi.com/2072-6694/16/16/2862

4. “Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers”
by Prerna Dabral, Nobel Bhasin,Manish Ranjan, Maysoon M. Makhlouf and Zakaria Y. Abd Elmageed
Cancers 2024, 16(13), 2462; https://doi.org/10.3390/cancers16132462
Available online: https://www.mdpi.com/2072-6694/16/13/2462

5. “Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review”
by Karam Ashouri, Alexandra Wong, Pooja Mittal, Lesly Torres-Gonzalez, Jae Ho Lo, Shivani Soni, Sandra Algaze, Taline Khoukaz, Wu Zhang, Yan Yang, Joshua Millstein et al.
Cancers 2024, 16(16), 2796; https://doi.org/10.3390/cancers16162796
Available online: https://www.mdpi.com/2072-6694/16/16/2796 

6. “Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer”
by Christina Loukopoulou, Taxiarchis Nikolouzakis, Ioannis Koliarakis, Elena Vakonaki and John Tsiaoussis
Cancers 2024, 16(19), 3370; https://doi.org/10.3390/cancers16193370
Available online: https://www.mdpi.com/2072-6694/16/19/3370

7. “Defensins: Exploring Their Opposing Roles in Colorectal Cancer Progression”
by Hussein Sabit, Timothy M. Pawlik, Shaimaa Abdel-Ghany and Borros Arneth
Cancers 2024, 16(15), 2622; https://doi.org/10.3390/cancers16152622
Available online: https://www.mdpi.com/2072-6694/16/15/2622 

8. “Enhancing Immunotherapy Response Prediction in Metastatic Lung Adenocarcinoma: Leveraging Shallow and Deep Learning with CT-Based Radiomics across Single and Multiple Tumor Sites”
by Cécile Masson-Grehaigne, Mathilde Lafon, Jean Palussière, Laura Leroy, Benjamin Bonhomme, Eva Jambon, Antoine Italiano, Sophie Cousin and Amandine Crombé
Cancers 2024, 16(13), 2491; https://doi.org/10.3390/cancers16132491
Available online: https://www.mdpi.com/2072-6694/16/13/2491

9. “Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma”
by Cassandra Cieslak, Carsten Hain, Christian Rückert-Reed, Tobias Busche, Levin Joe Klages, Katrin Schaper-Gerhardt, Ralf Gutzmer, Jörn Kalinowski and Rudolf Stadler
Cancers 2024, 16(21), 3700; https://doi.org/10.3390/cancers16213700
Available online: https://www.mdpi.com/2072-6694/16/21/3700

10. “Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin’s Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence”
by Sandra Maria Barbalho, Karina Torres Pomini, Enzo Pereira de Lima, Jéssica da Silva Camarinha Oliveira, Beatriz Leme Boaro, Adriano Cressoni Araújo, Elen Landgraf Guiguer, Rose Eli Grassi Rici, Durvanei Augusto Maria, Jesselina Francisco dos Santos Haber et al.
Cancers 2024, 16(22), 3758; https://doi.org/10.3390/cancers16223758
Available online: https://www.mdpi.com/2072-6694/16/22/3758

11. “Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326”
by Constantin-Dan Tâlvan, Elena-Teodora Tâlvan, Călin Ilie Mohor, Liviuța Budișan, Valentin Grecu, Manuela Mihalache, Oana Zănoagă, Sergiu Chira, Ioana Berindan-Neagoe, Victor Cristea et al.
Cancers 2024, 16(12), 2285; https://doi.org/10.3390/cancers16122285
Available online: https://www.mdpi.com/2072-6694/16/12/2285

12. “Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?”
by Felix Peisen, Annika Gerken, Alessa Hering, Isabel Dahm, Konstantin Nikolaou, Sergios Gatidis, Thomas K. Eigentler, Teresa Amaral, Jan H. Moltz and Ahmed E. Othman
Cancers 2024, 16(15), 2669; https://doi.org/10.3390/cancers16152669
Available online: https://www.mdpi.com/2072-6694/16/15/2669

13. “Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer?”
by Alvan Cai, Yuan Chen, Lily S. Wang, John K. Cusick and Yihui Shi
Cancers 2024, 16(15), 2635; https://doi.org/10.3390/cancers16152635
Available online: https://www.mdpi.com/2072-6694/16/15/2635

14. “Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications?”
by Margo B. Gerke, Caroline S. Jansen and Mehmet A. Bilen
Cancers 2024, 16(12), 2280; https://doi.org/10.3390/cancers16122280
Available online: https://www.mdpi.com/2072-6694/16/12/2280

15. “Artificial Intelligence in Head and Neck Cancer Diagnosis: A Comprehensive Review with Emphasis on Radiomics, Histopathological, and Molecular Applications?”
by Giuseppe Broggi, Antonino Maniaci, Mario Lentini, Andrea Palicelli, Magda Zanelli, Maurizio Zizzo, Nektarios Koufopoulos, Serena Salzano, Manuel Mazzucchelli and Rosario Caltabiano
Cancers 2024, 16(21), 3623; https://doi.org/10.3390/cancers16213623
Available online: https://www.mdpi.com/2072-6694/16/21/3623

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office